2,101
Views
91
CrossRef citations to date
0
Altmetric
Original Research

Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma

, , , , , , , , & show all
Article: e1019981 | Received 09 Jan 2015, Accepted 11 Feb 2015, Published online: 27 Jul 2015
 

Abstract

Neuroblastoma grows within an intricate network of different cell types including epithelial, stromal and immune cells. The presence of tumor-infiltrating T cells is considered an important prognostic indicator in many cancers, but the role of these cells in neuroblastoma remains to be elucidated. Herein, we examined the relationship between the type, density and organization of infiltrating T cells and clinical outcome within a large collection of neuroblastoma samples by quantitative analysis of immunohistochemical staining. We found that infiltrating T cells have a prognostic value greater than, and independent of, the criteria currently used to stage neuroblastoma. A variable in situ structural organization and different concurrent infiltration of T-cell subsets were detected in tumors with various outcomes. Low-risk neuroblastomas were characterized by a higher number of proliferating T cells and a more structured T-cell organization, which was gradually lost in tumors with poor prognosis. We defined an immunoscore based on the presence of CD3+, CD4+ and CD8+ infiltrating T cells that associates with favorable clinical outcome in MYCN-amplified tumors, improving patient survival when combined with the v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN) status. These findings support the hypothesis that infiltrating T cells influence the behavior of neuroblastoma and might be of clinical importance for the treatment of patients.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Acknowledgments

The authors thank A. Alisi, G. Jurman and M. Rosado for critical reading of the manuscript.

Funding

This work was supported by Italian Ministry of Health (Rome, Italy) grant PE-2011-02351866 (DF) and the Special Project “5 × 1000” Associazione Italiana per la Ricerca sul Cancro (AIRC, Milan, Italy) grant 9962 (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation on the manuscript.

Supplemental Material

Supplemental data for this article can be accessed on the publisher's website.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.